Uses And Benefits
In the United States, trifarotene is approved to treat acne vulgaris in patients who are at least nine years old. This medicated cream is also approved in the United States and Europe as a designated 'orphan drug' to treat congenital ichthyosis. This rare condition is associated with skin dryness, scaling, and thickening.
Other retinoic acid receptor agonists treat facial acne. However, studies have shown that trifarotene is the only one that is effective at treating both facial acne and acne that occurs on the trunk, including the back, shoulders, and chest. During clinical trials, patients who received trifarotene had a significant reduction in facial acne in two weeks. Additionally, trials showed that acne on the trunk saw these benefits in four weeks.
Uncover the potential side effects of this medication next.